377 related articles for article (PubMed ID: 19761935)
21. Adrenergic receptor polymorphisms and platelet reactivity after treatment with dual antiplatelet therapy with aspirin and clopidogrel in acute coronary syndrome.
Cuisset T; Hamilos M; Delrue M; Frère C; Verhamme K; Bartunek J; Saut N; Bonnet JL; Eijgelsheim M; Wijns W; Alessi MC; Barbato E
Thromb Haemost; 2010 Apr; 103(4):774-9. PubMed ID: 20135061
[TBL] [Abstract][Full Text] [Related]
22. The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel.
Ogilvie BW; Yerino P; Kazmi F; Buckley DB; Rostami-Hodjegan A; Paris BL; Toren P; Parkinson A
Drug Metab Dispos; 2011 Nov; 39(11):2020-33. PubMed ID: 21795468
[TBL] [Abstract][Full Text] [Related]
23. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
[TBL] [Abstract][Full Text] [Related]
24. Pharmacodynamic evaluation of pantoprazole therapy on clopidogrel effects: results of a prospective, randomized, crossover study.
Ferreiro JL; Ueno M; Tomasello SD; Capodanno D; Desai B; Dharmashankar K; Seecheran N; Kodali MK; Darlington A; Pham JP; Tello-Montoliu A; Charlton RK; Bass TA; Angiolillo DJ
Circ Cardiovasc Interv; 2011 Jun; 4(3):273-9. PubMed ID: 21521834
[TBL] [Abstract][Full Text] [Related]
25. Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study.
Arbel Y; Birati EY; Finkelstein A; Halkin A; Kletzel H; Abramowitz Y; Berliner S; Deutsch V; Herz I; Keren G; Banai S
Clin Cardiol; 2013 Jun; 36(6):342-6. PubMed ID: 23630016
[TBL] [Abstract][Full Text] [Related]
26. Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome.
Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Romero-Barra M; Camoin L; Lambert M; Juhan-Vague I; Bonnet JL; Alessi MC
Thromb Haemost; 2007 Feb; 97(2):212-7. PubMed ID: 17264949
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of high clopidogrel maintenance dose according to CYP2C19 genotypes in clopidogrel low responders undergoing coronary stenting for non ST elevation acute coronary syndrome.
Cuisset T; Quilici J; Cohen W; Fourcade L; Saut N; Pankert M; Gaborit B; Carrieri P; Morange PE; Bonnet JL; Alessi MC
Am J Cardiol; 2011 Sep; 108(6):760-5. PubMed ID: 21803320
[TBL] [Abstract][Full Text] [Related]
28. Calcium-channel blockers reduce the antiplatelet effect of clopidogrel.
Siller-Matula JM; Lang I; Christ G; Jilma B
J Am Coll Cardiol; 2008 Nov; 52(19):1557-63. PubMed ID: 19007592
[TBL] [Abstract][Full Text] [Related]
29. Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction.
Bonello L; Berbis J; Laine M; Armero S; Bessereau J; Jacquin L; Bonello C; Camillieri E; Barragan P; Dignat-George F; Paganelli F; Camoin-Jau L
Thromb Haemost; 2012 Jul; 108(1):101-6. PubMed ID: 22535315
[TBL] [Abstract][Full Text] [Related]
30. Omeprazole affects clopidogrel efficacy but not ischemic events in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention.
Ren YH; Zhao M; Chen YD; Chen L; Liu HB; Wang Y; Sun ZJ; Chen JS; Huang TT; Guo YS; Xie YJ; Wang CY
Chin Med J (Engl); 2011 Mar; 124(6):856-61. PubMed ID: 21518592
[TBL] [Abstract][Full Text] [Related]
31. Drug-drug interaction between clopidogrel and the proton pump inhibitors.
Norgard NB; Mathews KD; Wall GC
Ann Pharmacother; 2009 Jul; 43(7):1266-74. PubMed ID: 19470853
[TBL] [Abstract][Full Text] [Related]
32. Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel.
Siriswangvat S; Sansanayudh N; Nathisuwan S; Panomvana D
Circ J; 2010 Oct; 74(10):2187-92. PubMed ID: 20736505
[TBL] [Abstract][Full Text] [Related]
33. The influence of omeprazole on platelet inhibition of clopidogrel in various CYP2C19 mutant alleles.
Liu Q; Dang DS; Chen YF; Yan M; Shi GB; Zhao QC
Genet Test Mol Biomarkers; 2012 Nov; 16(11):1293-7. PubMed ID: 23046071
[TBL] [Abstract][Full Text] [Related]
34. [Impact of different proton pump inhibitors on the antiplatelet activity of clopidogrel in combination with aspirin for patients undergoing coronary stent implantation].
Cai J; Wu Q; Fan L; Liu CF; Wang ZG; Sun J
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 Aug; 26(3):266-9. PubMed ID: 21038666
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
Lettino M
Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan.
Lin CF; Shen LJ; Wu FL; Bai CH; Gau CS
Br J Clin Pharmacol; 2012 Nov; 74(5):824-34. PubMed ID: 22364155
[TBL] [Abstract][Full Text] [Related]
37. Pantoprazole Does Not Reduce the Antiplatelet Effect of Clopidogrel: A Randomized Controlled Trial in Korea.
Choi YJ; Kim N; Jang IJ; Cho JY; Nam RH; Park JH; Jo HJ; Yoon H; Shin CM; Park YS; Lee DH; Jung HC
Gut Liver; 2017 Jul; 11(4):504-511. PubMed ID: 28395507
[TBL] [Abstract][Full Text] [Related]
38. Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
Gurbel PA; Bliden KP; Fort JG; Jeong YH; Shuldiner A; Chai S; Gesheff T; Antonino M; Gesheff M; Zhang Y; Tantry US
Am Heart J; 2013 Feb; 165(2):176-82. PubMed ID: 23351820
[TBL] [Abstract][Full Text] [Related]
39. Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance) randomized study.
Jeong YH; Lee SW; Choi BR; Kim IS; Seo MK; Kwak CH; Hwang JY; Park SW
J Am Coll Cardiol; 2009 Mar; 53(13):1101-9. PubMed ID: 19324253
[TBL] [Abstract][Full Text] [Related]
40. Clopidogrel and proton pump inhibitors: is there a significant drug-drug interaction?
Shmulevich E; Friger M; Gilutz H; Azab AN
Can J Cardiovasc Nurs; 2011; 21(4):27-36. PubMed ID: 22165503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]